ABC News contributor Dr. Alok Patel and Ian Haddock, founder of the Normal Anomaly Initiative, discuss the FDA’s decision to approve the world’s only twice-a-year injectable form of PrEP.

A popular brand of children's cough syrup is under a voluntary recall over concerns it's contaminated with bacteria. The ...

GLP-1 medications such as Wegovy, Mounjaro and Ozempic helped drive a 9% year-over-year increase in U.S. prescription dispensing revenue, which reached $683 billion in 2024.  A separate report found ...

A children's cough syrup sold across the United States is being recalled due to a possible microbial contamination that can ...

Aligned with the recent FSSAI guidelines that support the Government of India’s Extended Producer Responsibility (EPR) ...